VP, GTM & Commercial Strategy — Real World Data at Inovalon — Remote

Location: This is a hybrid position based in our Tampa, FL office. Team members are currently expected to work onsite two days per week (Tuesdays and Wednesdays), with additional in-office days required as business needs dictate throughout the month.

Overview

The VP of GTM & Commercial Strategy is a senior commercial leader responsible for driving both the go-to-market execution and the strategic commercial agenda for Inovalon’s Real World Data (RWD) business. This is a true hybrid role — equally weighted between rigorous GTM operationalization and long-range commercial strategy — and serves as the critical link between customers, the sales organization, product teams, and senior leadership.

The role owns end-to-end commercialization for Inovalon’s RWD product portfolio, spanning closed and open claims, EHR and clinical notes data, and adjacent data assets and services. The RWD customer base includes life sciences organizations (biopharma, medical device, CROs, and health economics & outcomes research), as well as payers, providers, and other data-driven healthcare organizations. The VP will bring deep domain expertise in real world data and analytics markets and will be expected to operate with authority at both the strategic and executional level.

Reporting to the SVP of Commercial Strategy for the Insights business, this role partners closely with senior leaders across Sales, Product, Marketing, Finance, Legal, and Customer Success. It is a high-impact commercial leadership position with significant external visibility and meaningful influence on the growth trajectory of the Insights business unit.

Duties and Responsibilities

Commercial Strategy & Business Planning

• Lead and own the commercial strategy for Inovalon’s RWD business, including revenue targets, market segmentation, growth opportunity identification, and multi-year business planning in alignment with product roadmaps, sales capacity, and financial targets.
• Define and execute market segment strategies for RWD customers, with particular emphasis on the life sciences segment (biopharma, medical device, CROs, HEOR) and adjacent segments including payers and providers.
• Lead build/buy/partner decision frameworks and M&A evaluation for the RWD portfolio, identifying inorganic growth opportunities in collaboration with Sales, Product, Corporate Strategy, and other internal Inovalon functions.
• Translate enterprise strategy into actionable, segment-specific commercial plans for new products, add-ons, and expansions across the RWD portfolio.
• Support annual and multi-year business planning cycles, ensuring tight alignment across sales capacity, product roadmaps, pricing strategy, and financial targets.

Go-to-Market & Launch Execution

• Own GTM readiness and commercialization execution for new RWD products and enhancements, ensuring clear positioning, pricing, packaging, and enablement for sales and customer-facing teams.
• Establish and operationalize a repeatable commercialization model for the RWD portfolio, including scalable launch playbooks, portfolio governance, and operating cadences connecting product definition through market launch to post-launch performance.
• Lead quarterly product portfolio planning to define and maintain a clear Plan of Record, aligning product roadmap, market priorities, and commercial readiness across Product, Sales, and Engineering.
• Own post-launch performance tracking and continuous optimization, ensuring RWD products achieve targeted adoption, pipeline contribution, and revenue outcomes.
• Partner with Sales Engineering to evolve pre-sales support toward a strategic commercial capability, including early adopter validation, deal strategy input, and structured Voice of Customer capture.
• Ensure new product launches are rigorously evaluated for profitability and GTM viability, driving adoption, pipeline conversion, and early revenue realization.

Pricing & Monetization

• Own product and services pricing strategy for the RWD business, in close alignment with Product and Finance, developing pricing frameworks that balance growth, competitiveness, and margin discipline.